The metallo-β-lactamase NDM is able to inactivate the last-generation antibiotic cefiderocol (FDC), in contrast to the related enzymes VIM and IMP. These results provide clues for the therapeutic use of FDC.
β‐Lactamase‐catalysed hydrolysis is the primary form of β‐lactam antibiotic resistance in Gram‐negative bacteria. The penicillanic acid sulfone (PAS) enmetazobactam is thought to inhibit extended‐spectrum β‐lactamases (ESBLs) by fragmentation of an initial acyl‐enzyme to form an active‐site lysinoalanine cross link. We investigate interactions of enmetazobactam and its congener tazobactam with GES‐1, an ESBL with structural features of carbapenem‐hydrolysing β‐lactamases. Crystal structures show different breakdown products of the two inhibitors covalently bound to the catalytic Ser70, assigned using quantum mechanics/molecular mechanics (QM/MM) calculations. We find no evidence for lysinoalanine formation, with mass spectrometry indicating active enzyme regeneration, behaviour previously observed for carbapenem‐hydrolysing enzymes, but not ESBLs. This work establishes that PAS inhibitors interact with diverse β‐lactamases by differing mechanisms, which should inform development of future compounds.